Research advances in antiviral drugs and their treatment regimens in chronic hepatitis C / 临床肝胆病杂志
Journal of Clinical Hepatology
; (12): 2200-2204, 2017.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-663305
Biblioteca responsável:
WPRO
ABSTRACT
Chronic hepatitis C has become a serious public health issue around the world.In recent years,with the development of pharmacotherapy for hepatitis C,it may be possible to cure hepatitis C.With reference to the epidemic status of hepatitis C and the advantages and side effects of conventional standard therapy (pegylated interferon plus ribavirin) and various oral direct-acting antiviral agents (DAAs),this article summarizes the advantages and disadvantages of different combinations of DAAs in the treatment of chronic hepatitis C with different genotypes and briefly introduces the World Health Organization recommendations on the treatment of hepatitis C.Hepatitis C is expected to be eliminated with the development of pharmacotherapy for chronic hepatitis C.
Texto completo:
Disponível
Contexto em Saúde:
ODS3 - Meta 3.7 Acesso universal aos serviços de saude reprodutiva
/
ODS3 - Saúde e Bem-Estar
Problema de saúde:
Infecções Sexualmente Transmissíveis: Prevenção e Cuidados
/
Meta 3.8 Atingir a cobertura universal de saúde
/
Meta 3.3: Acabar com as doenças tropicais negligenciadas e combater as doenças transmissíveis
Base de dados:
WPRIM (Pacífico Ocidental)
Tipo de estudo:
Guia de prática clínica
Idioma:
Chinês
Revista:
Journal of Clinical Hepatology
Ano de publicação:
2017
Tipo de documento:
Artigo